Bridgeway Capital Management’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,400
| Closed | -$69.7K | – | 1415 |
|
|
2023
Q2 | $69.7K | Hold |
8,400
| – | – | ﹤0.01% | 1304 |
|
|
2023
Q1 | $37K | Hold |
8,400
| – | – | ﹤0.01% | 1333 |
|
|
2022
Q4 | $49.6K | Hold |
8,400
| – | – | ﹤0.01% | 1296 |
|
|
2022
Q3 | $59K | Hold |
8,400
| – | – | ﹤0.01% | 1338 |
|
|
2022
Q2 | $122K | Buy |
+8,400
| New | +$122K | ﹤0.01% | 1193 |
|